ER stress is associated with reduced ABCA-1 protein levels in macrophages treated with advanced glycated albumin - Reversal by a chemical chaperone


Autoria(s): Castilho, Gabriela; Okuda, Ligia S.; Pinto, Raphael S.; Iborra, Rodgiro T.; Nakandakare, Edna R.; Santos, Celio X.; Laurindo, Francisco R.; Passarelli, Marisa
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

06/11/2013

06/11/2013

2012

Resumo

ATP-binding cassette transporter A1 mediates the export of excess cholesterol from macrophages, contributing to the prevention of atherosclerosis. Advanced glycated albumin (AGE-alb) is prevalent in diabetes mellitus and is associated with the development of atherosclerosis. Independently of changes in ABCA-1 mRNA levels, AGE-alb induces oxidative stress and reduces ABCA-1 protein levels, which leads to macrophage lipid accumulation. These metabolic conditions are known to elicit endoplasmic reticulum (ER) stress. We sought to determine if AGE-alb induces ER stress and unfolded protein response (UPR) in macrophages and how disturbances to the ER could affect ABCA-1 content and cholesterol efflux in macrophages. AGE-alb induced a time-dependent increase in ER stress and UPR markers. ABCA-1 content and cellular cholesterol efflux were reduced by 33% and 47%, respectively, in macrophages treated with AGE-alb, and both were restored by treatment with 4-phenyl butyric acid (a chemical chaperone that alleviates ER stress), but not MG132 (a proteasome inhibitor). Tunicamycin, a classical ER stress inductor, also impaired ABCA-1 expression and cholesterol efflux (showing a decrease of 61% and 82%, respectively), confirming the deleterious effect of ER stress in macrophage cholesterol accumulation. Glycoxidation induces macrophage ER stress, which relates to the reduction in ABCA-1 and in reverse cholesterol transport, endorsing the adverse effect of macrophage ER stress in atherosclerosis. Thus, chemical chaperones that alleviate ER stress may represent a useful tool for the prevention and treatment of atherosclerosis in diabetes. (C) 2012 Elsevier Ltd. All rights reserved.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/53869-9, 10/50108-4, 09/54688-8, 10/50147-0]

Fundacao Faculdade de Medicina

Laboratorios de Investigacao Medica (LIM-HC)

Identificador

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, OXFORD, v. 44, n. 7, pp. 1078-1086, JUL, 2012

1357-2725

http://www.producao.usp.br/handle/BDPI/41977

10.1016/j.biocel.2012.03.016

http://dx.doi.org/10.1016/j.biocel.2012.03.016

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

OXFORD

Relação

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Direitos

closedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #DIABETES MELLITUS #ADVANCED GLYCATED ALBUMIN #ENDOPLASMIC RETICULUM STRESS #ABCA-1 #ATHEROSCLEROSIS #REVERSE CHOLESTEROL TRANSPORT #ENDOPLASMIC-RETICULUM STRESS #CHOLESTEROL EFFLUX #END-PRODUCTS #ATHEROSCLEROTIC PLAQUES #DIABETES-MELLITUS #EXPRESSION #TRANSPORT #DISEASE #GLUCOSE #PREVENT #BIOCHEMISTRY & MOLECULAR BIOLOGY #CELL BIOLOGY
Tipo

article

original article

publishedVersion